Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 12-Apr-24 7:35 PM View:  | Kwietniak Matthew R. Chief Commercial Officer | Peregrine Pharmaceuticals I... (CDMO) | 11-Apr-24 | Option Exercise | 669 | -- | -- | 3% 22.36K to 23.03K | |
| 11-Apr-24 7:43 PM View: | Richieri Richard A. Chief Operations Officer | Peregrine Pharmaceuticals I... (CDMO) | 09-Apr-24 | Option Exercise | 254 | -- | -- | < 1% 33.34K to 33.6K | |
| 11-Apr-24 7:44 PM View: | Ziebell Mark R V. P., General Counsel | Peregrine Pharmaceuticals I... (CDMO) | 09-Apr-24 | Option Exercise | 3,208 | -- | -- | 5% 63.27K to 66.48K | |
| 11-Apr-24 7:40 PM View: | Green Nicholas Stewart President & CEO Director | Peregrine Pharmaceuticals I... (CDMO) | 09-Apr-24 | Option Exercise | 22,877 | -- | -- | 12% 192.49K to 215.37K | |
| 11-Apr-24 7:41 PM View: | Hart Daniel Ryan Chief Financial Officer | Peregrine Pharmaceuticals I... (CDMO) | 09-Apr-24 | Option Exercise | 5,742 | -- | -- | 7% 79.31K to 85.05K | |
| 11-Apr-24 7:42 PM View: | Kwietniak Matthew R. Chief Commercial Officer | Peregrine Pharmaceuticals I... (CDMO) | 09-Apr-24 | Option Exercise | 2,532 | -- | -- | 13% 19.83K to 22.36K | |
| 11-Apr-24 7:43 PM View: | Richieri Richard A. Chief Operations Officer | Peregrine Pharmaceuticals I... (CDMO) | 09-Apr-24 | Option Exercise | 2,512 | -- | -- | 8% 30.83K to 33.34K | |
| 12-Jan-24 7:34 PM View: | Kwietniak Matthew R. Chief Commercial Officer | Peregrine Pharmaceuticals I... (CDMO) | 12-Jan-24 | Option Sale | 274 | $6.77 | $1,854.98 | (1%) 20.1K to 19.83K | |
| 12-Jan-24 7:34 PM View: | Kwietniak Matthew R. Chief Commercial Officer | Peregrine Pharmaceuticals I... (CDMO) | 11-Jan-24 | Option Exercise | 669 | -- | -- | 3% 19.43K to 20.1K | |
| 11-Jan-24 7:37 PM View: | Kwietniak Matthew R. Chief Commercial Officer | Peregrine Pharmaceuticals I... (CDMO) | 10-Jan-24 | Option Sale | 1,060 | $6.17 | $6,539.99 | (5%) 20.49K to 19.43K | |
| 11-Jan-24 7:36 PM View: | Hart Daniel Ryan Chief Financial Officer | Peregrine Pharmaceuticals I... (CDMO) | 10-Jan-24 | Option Sale | 2,408 | $6.17 | $14,856.60 | (3%) 81.71K to 79.31K | |
| 11-Jan-24 7:38 PM View: | Richieri Richard A. Chief Operations Officer | Peregrine Pharmaceuticals I... (CDMO) | 10-Jan-24 | Option Sale | 1,055 | $6.17 | $6,509.35 | (3%) 32.0K to 30.95K | |
| 11-Jan-24 7:38 PM View: | Richieri Richard A. Chief Operations Officer | Peregrine Pharmaceuticals I... (CDMO) | 10-Jan-24 | Option Sale | 116 | $6.17 | $715.72 | (< 1%) 30.95K to 30.83K | |
| 11-Jan-24 7:39 PM View: | Ziebell Mark R V. P., General Counsel | Peregrine Pharmaceuticals I... (CDMO) | 10-Jan-24 | Option Sale | 1,346 | $6.17 | $8,304.82 | (2%) 64.61K to 63.27K | |
| 11-Jan-24 7:37 PM View: | Kwietniak Matthew R. Chief Commercial Officer | Peregrine Pharmaceuticals I... (CDMO) | 09-Jan-24 | Option Exercise | 2,533 | -- | -- | 14% 17.96K to 20.49K | |
| 11-Jan-24 7:38 PM View: | Richieri Richard A. Chief Operations Officer | Peregrine Pharmaceuticals I... (CDMO) | 09-Jan-24 | Option Exercise | 2,512 | -- | -- | 9% 29.24K to 31.75K | |
| 11-Jan-24 7:39 PM View: | Ziebell Mark R V. P., General Counsel | Peregrine Pharmaceuticals I... (CDMO) | 09-Jan-24 | Option Exercise | 3,208 | -- | -- | 5% 61.41K to 64.61K | |
| 11-Jan-24 7:36 PM View: | Hart Daniel Ryan Chief Financial Officer | Peregrine Pharmaceuticals I... (CDMO) | 09-Jan-24 | Option Exercise | 5,740 | -- | -- | 8% 75.97K to 81.71K | |
| 11-Jan-24 7:38 PM View: | Richieri Richard A. Chief Operations Officer | Peregrine Pharmaceuticals I... (CDMO) | 09-Jan-24 | Option Exercise | 255 | -- | -- | < 1% 31.75K to 32.0K | |
| 11-Jan-24 7:35 PM View: | Green Nicholas Stewart President & CEO Director | Peregrine Pharmaceuticals I... (CDMO) | 09-Jan-24 | Option Exercise | 22,879 | -- | -- | 13% 169.61K to 192.49K | |
| 03-Jan-24 7:55 PM View: | Richieri Richard A. Chief Operations Officer | Peregrine Pharmaceuticals I... (CDMO) | 29-Dec-23 | Acquisition (other) Duplicate | 892 | $5.53 | $4,928.30 | 3% 28.34K to 29.24K | |
| 03-Jan-24 7:56 PM View: | Ziebell Mark R V. P., General Counsel | Peregrine Pharmaceuticals I... (CDMO) | 29-Dec-23 | Acquisition (other) | 892 | $5.53 | $4,928.30 | 1% 60.52K to 61.41K | |
| 03-Jan-24 7:53 PM View: | Hart Daniel Ryan Chief Financial Officer | Peregrine Pharmaceuticals I... (CDMO) | 29-Dec-23 | Acquisition (other) | 892 | $5.53 | $4,928.30 | 1% 75.08K to 75.97K | |
| 03-Jan-24 7:51 PM View: | Green Nicholas Stewart President & CEO Director | Peregrine Pharmaceuticals I... (CDMO) | 29-Dec-23 | Acquisition (other) | 892 | $5.53 | $4,928.30 | < 1% 168.72K to 169.61K | |
| 03-Jan-24 7:55 PM View: | Richieri Richard A. Chief Operations Officer | Peregrine Pharmaceuticals I... (CDMO) | 29-Dec-23 | Acquisition (other) | 892 | $5.53 | $4,928.30 | 3% 27.45K to 28.34K | |
| 18-Dec-23 7:31 PM View: | Hancock Richard B Director | Peregrine Pharmaceuticals I... (CDMO) | 15-Dec-23 | Purchase | 23,000 | $5.86 | $134,734.00 | 41% 55.76K to 78.76K | |
| 18-Dec-23 7:34 PM View: | Thoma Jeanne Director | Peregrine Pharmaceuticals I... (CDMO) | 14-Dec-23 | Option Exercise | 9,612 | -- | -- | 104% 9.24K to 18.86K | |
| 18-Dec-23 7:30 PM View: | Carleone Joseph Director | Peregrine Pharmaceuticals I... (CDMO) | 14-Dec-23 | Option Exercise | 9,612 | -- | -- | 10% 93.96K to 103.57K | |
| 18-Dec-23 7:31 PM View: | Hancock Richard B Director | Peregrine Pharmaceuticals I... (CDMO) | 14-Dec-23 | Option Exercise | 9,612 | -- | -- | 21% 46.15K to 55.76K | |
| 18-Dec-23 7:32 PM View: | MacKey Catherine J Director | Peregrine Pharmaceuticals I... (CDMO) | 14-Dec-23 | Option Exercise | 9,612 | -- | -- | 137% 7.01K to 16.62K | |
| 18-Dec-23 7:33 PM View: | Sargen Gregory Director | Peregrine Pharmaceuticals I... (CDMO) | 14-Dec-23 | Option Exercise | 9,612 | -- | -- | 100% 0 to 9.61K | |
| 18-Dec-23 7:29 PM View: | Alegria Esther M. Director | Peregrine Pharmaceuticals I... (CDMO) | 14-Dec-23 | Option Exercise | 9,612 | -- | -- | 1395% 0.69K to 10.3K | |
| 10-Jan-24 7:56 PM View: | Hancock Richard B Director | Peregrine Pharmaceuticals I... (CDMO) | 13-Dec-23 | Private Purchase | 38,803 | $5.21 | $202,036.00 | 49% 78.76K to 117.56K | |
| 05-Dec-23 7:33 PM View: | Thoma Jeanne Director | Peregrine Pharmaceuticals I... (CDMO) | 03-Dec-23 | Option Exercise | 1,537 | -- | -- | 20% 7.71K to 9.24K | |
| 13-Oct-23 6:00 PM View: | Kwietniak Matthew R. Chief Commercial Officer | Peregrine Pharmaceuticals I... (CDMO) | 12-Oct-23 | Option Sale | 255 | $9.19 | $2,343.50 | (1%) 18.22K to 17.96K | |
| 13-Oct-23 6:00 PM View: | Kwietniak Matthew R. Chief Commercial Officer | Peregrine Pharmaceuticals I... (CDMO) | 11-Oct-23 | Option Exercise | 670 | -- | -- | 4% 17.55K to 18.22K | |
| 11-Oct-23 7:58 PM View: | Hart Daniel Ryan Chief Financial Officer | Peregrine Pharmaceuticals I... (CDMO) | 10-Oct-23 | Option Sale | 2,040 | $9.20 | $18,767.20 | (3%) 77.12K to 75.08K | |
| 11-Oct-23 7:59 PM View: | Richieri Richard A. Chief Operations Officer | Peregrine Pharmaceuticals I... (CDMO) | 10-Oct-23 | Option Sale | 894 | $9.20 | $8,224.44 | (3%) 28.46K to 27.57K | |
| 11-Oct-23 7:59 PM View: | Richieri Richard A. Chief Operations Officer | Peregrine Pharmaceuticals I... (CDMO) | 10-Oct-23 | Option Sale | 112 | $9.20 | $1,030.40 | (< 1%) 27.57K to 27.45K | |
| 11-Oct-23 7:58 PM View: | Kwietniak Matthew R. Chief Commercial Officer | Peregrine Pharmaceuticals I... (CDMO) | 10-Oct-23 | Option Sale | 970 | $9.20 | $8,923.61 | (5%) 18.52K to 17.55K | |
| 11-Oct-23 7:59 PM View: | Ziebell Mark R V. P., General Counsel | Peregrine Pharmaceuticals I... (CDMO) | 10-Oct-23 | Option Sale | 1,141 | $9.20 | $10,496.70 | (2%) 61.66K to 60.52K | |
| 11-Oct-23 7:53 PM View: | Green Nicholas Stewart President & CEO Director | Peregrine Pharmaceuticals I... (CDMO) | 09-Oct-23 | Option Exercise | 22,876 | -- | -- | 16% 145.84K to 168.72K | |
| 11-Oct-23 7:58 PM View: | Kwietniak Matthew R. Chief Commercial Officer | Peregrine Pharmaceuticals I... (CDMO) | 09-Oct-23 | Option Exercise | 2,532 | -- | -- | 16% 15.98K to 18.52K | |
| 11-Oct-23 7:59 PM View: | Richieri Richard A. Chief Operations Officer | Peregrine Pharmaceuticals I... (CDMO) | 09-Oct-23 | Option Exercise | 2,511 | -- | -- | 10% 25.69K to 28.2K | |
| 11-Oct-23 7:58 PM View: | Hart Daniel Ryan Chief Financial Officer | Peregrine Pharmaceuticals I... (CDMO) | 09-Oct-23 | Option Exercise | 5,741 | -- | -- | 8% 71.38K to 77.12K | |
| 11-Oct-23 7:59 PM View: | Richieri Richard A. Chief Operations Officer | Peregrine Pharmaceuticals I... (CDMO) | 09-Oct-23 | Option Exercise | 254 | -- | -- | < 1% 28.2K to 28.46K | |
| 11-Oct-23 7:59 PM View: | Ziebell Mark R V. P., General Counsel | Peregrine Pharmaceuticals I... (CDMO) | 09-Oct-23 | Option Exercise | 3,207 | -- | -- | 5% 58.45K to 61.66K | |
| 22-Sep-23 12:51 PM View: | Carleone Joseph Director | Peregrine Pharmaceuticals I... (CDMO) | 21-Sep-23 | Private Purchase | 20,000 | $9.53 | $190,696.00 | 27% 73.96K to 93.96K | |
| 01-Aug-23 7:29 PM View: | Green Nicholas Stewart President & CEO Director | Peregrine Pharmaceuticals I... (CDMO) | 31-Jul-23 | Option Sale | 19,519 | $12.99 | $253,552.00 | (12%) 165.36K to 145.84K | |
| 01-Aug-23 7:29 PM View: | Green Nicholas Stewart President & CEO Director | Peregrine Pharmaceuticals I... (CDMO) | 30-Jul-23 | Option Exercise | 37,500 | -- | -- | 29% 127.86K to 165.36K |
